Navigation Links
HFSP research funding for the Helmholtz Zentrum München
Date:3/27/2014

The Human Frontier Science Program (HFSP) funds innovative research work in the field of life sciences. The organization's members are Australia, Canada, France, Germany, Great Britain, India, Italy, Japan, New Zealand, Norway, South Korea, Switzerland and the USA, as well as the EU. Research grants are awarded to international research collaborations that carry out interdisciplinary work in order to develop cutting edge approaches to fundamental issues in the life sciences.

Oxidized lipidomes: Key figures in non-apoptotic cell death

Oxidative modifications of lipids are a key process in non-apoptotic cell death signalling and play important roles in a number of relevant diseases, such as neurodegeneration, diabetes and asthma. A team of scientists headed by Dr. Marcus Conrad from the Institute of Developmental Genetics (IDG) at the Helmholtz Zentrum Mnchen (HMGU) now strives to intensify research into the underlying molecular mechanisms. The overall goal of this program is to identify the specific signature of oxidized lipids and to decipher the interaction of these modified lipids with signal molecules that ultimately promote non-apoptotic cell death. Knowledge gained by this approach should lead to the development of a language code that, in turn, may provide cues for the design of novel treatment strategies. The partners in the project are Dr. Valerian Kagan, University of Pittsburgh (USA), Dr. Fulvio Ursini, University of Padova (Italy) and Dr. Judith Klein-Seetharaman, Warwick Medical School, Coventry (UK).

Mechanosensation: transmission and perception of neuronal stimuli

Movement and coordination must be modulated according to the environment. They are subject to permanent feedback from the perceived stimuli and adequate adaptive responses. With respect to the perceived signals, it is necessary to distinguish between external influences and self-generated stimuli a capability that makes highly differentiated motor sequences possible. The scientists headed by Dr. Hrnan Lpez-Schier from the Sensory Biology and Organogenesis (SBO) research unit at the HMGU want to uncover the underlying mechanosensation circuits and precisely characterize the involved nerve cells and genes. Partners in the project are Prof. Florian Engert, Harvard University (USA) and Dr. Ana Belen Elgoyhen, INGEBI-CONICET in Buenos Aires (Argentina).


'/>"/>

Contact: Press Office
presse@helmholtz-muenchen.de
49-893-187-2711
Helmholtz Zentrum Mnchen - German Research Center for Environmental Health
Source:Eurekalert

Related biology news :

1. UGA researchers explore function of cancer-causing gene
2. CASIS-sponsored research heads to space station aboard SpaceX-3
3. Distinguished researcher to speak at NJIT on preventing bone loss
4. Researchers present comprehensive roadmap of blood cells
5. Research produces strong evidence for a new class of antidepressant drugs
6. UT Southwestern ob/gyn researchers studying genetic factors in premature births
7. Researchers issue state-of-the-state on genetic-based testing & treatment for breast cancer
8. Deep ocean current may slow due to climate change, Penn research finds
9. NIH grants up to $28 million to group led by Scripps Research for work on ebola treatment
10. Heidelberg researcher awarded Animal Welfare Prize of the German Research Foundation
11. Jump start for frontier projects: The 2014 HFSP Research Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... December 7, 2016 According to a new market research ... Tool (Facial Expression, Voice Recognition), Service, Application Area, End User, And Region - ... grow from USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, ... Continue Reading ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 7, 2016   Veridium , a leader ... of new CEO James Stickland . Stickland, ... of experience, has served in senior executive roles ... specialized in expanding a pipeline of venture capital ... most recently served as managing director of U.K.-based ...
(Date:12/6/2016)... , Dec. 6, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... jointly announced today a five (5) year funding ... agreement to expand the rehabilitation and reentry support ... PEP History Established in 2004, the Prison Entrepreneurship ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, a ... heart failure and type 2 diabetes, announced that ... novel adeno-associated virus (AAV) vector developed in the ... Ph.D., at Stanford University. The company plans to ... gene therapy product pipeline. "Early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard ...
(Date:12/8/2016)... 2016  Anaconda BioMed S.L., a pre-clinical stage medical ... generation neuro-thrombectomy system for the treatment of Acute Ischemic ... MD to join its Scientific Advisory Board (SAB). The ... of scientific and clinical experts to Anaconda BioMed S.L., ... BRAIN ® to its clinical phase. The SAB ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, ... uBiome is one of just six company finalists in the Health & Medicine ... uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, ...
Breaking Biology Technology: